neurological diseases

BOSTON, MA and SEOUL, South Korea, June 22 2026 Insilico Medicine and SK Biopharmaceuticals have announced a landmark artificial...

GENEVA, Switzerland — December 23, 2025 — MindMaze Therapeutics, a commercial-stage innovator in evidence-based, precision digital treatments for neurological...